Oruka Therapeutics (ORKA) Preferred Shares (2024 - 2026)

Oruka Therapeutics' Preferred Shares history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.9 million, changed 0.0% from the prior year.
• Preferred Shares held at $2.9 million in Q1 2026 per ORKA's latest filing, from $2.9 million in the prior quarter.
• Across five years, Preferred Shares topped out at $52.8 million in Q3 2024 and bottomed at $2.9 million in Q4 2024.
• The 3-year median for Preferred Shares is $2.9 million (2024), against an average of $10.1 million.
• Biggest YoY gain for Preferred Shares was 0.0% in 2025; the steepest drop was 94.45% in 2025.
• Year by year, Preferred Shares stood at $2.9 million in 2024, then changed by 0.0% to $2.9 million in 2025, then changed by 0.0% to $2.9 million in 2026.
• Per Business Quant, the three latest ORKA Preferred Shares figures stand at $2.9 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025).